FOLFIRINOX has become the standard of care for metastatic pancreatic cancer. It has promising results and has improved survival for pancreatic cancer. FOLFIRINOX is a 4-drug treatment regimen, consisting of 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin. It’s producing the greatest prolonging
FOLFIRINOX and Pancreatic Cancer
